Sign in

CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851763759
Phone
919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale President, CEO and Director sold 500,000 shares at $3.12 ($1,558,750)
  6. 4 Open-market sale Director sold 500,000 shares at $3.12 ($1,558,750)
  7. 4 Open-market sale 10% owner sold 500,000 shares at $3.12 ($1,558,750)
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Open-market sale President, CEO and Director sold 4,875,000 shares at $2.60 ($12,675,000)
  11. 4 Open-market sale Director sold 4,875,000 shares at $2.60 ($12,675,000)
  12. 4 Open-market sale 10% owner sold 4,875,000 shares at $2.60 ($12,675,000)
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. 8-K Event Shareholder vote results
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Open-market sale President, CEO and Director sold 2,625,000 shares at $2.75 ($7,218,750)
  18. 4 Open-market sale Chief Operating Officer sold 23,402 shares at an average $4.01 ($93,904)
  19. 4 Open-market sale Director sold 2,625,000 shares at $2.75 ($7,218,750)
  20. 4 Open-market sale 10% owner sold 2,625,000 shares at $2.75 ($7,218,750)

Page 14 of 26 · 506 filings